NERVNasdaqPharmaceutical PreparationsFiscal year ends December 31
Minerva Neurosciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$2.32−0.03 (-1.28%)
Close on Oct 19, 2026
- Market cap
- $183.52M
- P/E (TTM)
- –
- Dividend yield
- –
Minerva Neurosciences statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Minerva Neurosciences | Industry median |
|---|---|---|
| Market Cap | $110.77M | $166.30M |
| Enterprise Value | $35.51M | $88.19M |
Income (trailing twelve months)
| Measure | Minerva Neurosciences | Industry median |
|---|---|---|
| Operating Income | -$35.14M | -$21.40M |
| Net Income | -$394.35M | -$22.46M |
| EBITDA | -$35.14M | -$16.91M |
Returns
| Measure | Minerva Neurosciences | Industry median |
|---|---|---|
| Return on Assets (ROA) | -628.4% | -40.9% |
| Return on Capital Employed (ROCE) | -38.6% | -38.1% |
Growth
| Measure | Minerva Neurosciences | Industry median |
|---|---|---|
| Net Income Growth (YoY) | -3611.7% | -35.2% |
Balance sheet
| Measure | Minerva Neurosciences | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $75.27M | $61.43M |
| Net Cash (Debt) | $75.27M | $15.35M |
| Net Cash Per Share | $1.58 | $0.66 |
| Equity (Book Value) | -$213.30M | $49.09M |
| Book Value Per Share | -$4.47 | $1.37 |
| Tangible Book Value | -$228.17M | $23.52M |
| Working Capital | $75.77M | $76.81M |
Financial position
| Measure | Minerva Neurosciences | Industry median |
|---|---|---|
| Current Ratio | 20.14 | 3.34 |
| Quick Ratio | 19.02 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Minerva Neurosciences | Industry median |
|---|---|---|
| Operating Cash Flow | -$26.17M | -$12.35M |
Efficiency
| Measure | Minerva Neurosciences | Industry median |
|---|---|---|
| Profits Per Employee | -$56.34M | -$703.34K |
| Employee Count | 7 | 74 |
Dividends and yields
| Measure | Minerva Neurosciences | Industry median |
|---|---|---|
| Earnings Yield | -356.0% | -23.3% |
Shares
| Measure | Minerva Neurosciences | Industry median |
|---|---|---|
| Shares Outstanding | 47,747,600 | 58,127,000 |
| Shares Change (YoY) | 368.2% | 10.9% |
| Shares Change (QoQ) | 7.72% | 0.54% |
| Float | 45,749,300 | 49,136,700 |
| Shares Held by Insiders | 4.19% | 11.6% |
| Shares Held by Institutions | 88.6% | 59.4% |
Scores
| Measure | Minerva Neurosciences | Industry median |
|---|---|---|
| Altman Z-Score | -11.77 | -0.22 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from Minerva Neurosciences's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.